SALT LAKE CITY, Dec. 6, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development ...
SALT LAKE CITY, May 7, 2018 /PRNewswire/ -- Recursion Pharmaceuticals today announced the award of a $546,000 grant from the Bill & Melinda Gates Foundation to apply Recursion's AI-enabled technology ...
SALT LAKE CITY, July 13, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, ...
- Promoted Ron Alfa M.D., Ph.D. to Senior Vice President of Research, to assume the responsibilities of outgoing Chief Scientific Officer Sharath Hegde, Ph.D. and further strengthen our commitment to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback